Bruce Mackle | LifeSci Advisors |
Steven Fruchtman | CEO, President & Director |
Mark Gelder | Chief Medical Officer |
Mark Guerin | CFO & COO |
Edouard Mullarky | Guggenheim Securities |
Ahu Demir | Ladenburg Thalmann & Co. |
Joseph Pantginis | H.C. Wainwright & Co. |
Robert LeBoyer | NOBLE Capital Markets |
Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Business Update Conference Call. [Operator Instructions].
At this time, I would like to turn the call over to Bruce Mackle of LifeSci Advisors.
Thank you, operator, and welcome, everyone, to Onconova's fourth quarter and full year 2022 financial results and business update conference call.